LIBRE LIFE: INTRODUCTION
Libre Life is our library of resources for supporting all those wearing a continuous glucose monitor, or CGM. Please take a look at the array of sources to help you get more from your Libre Life.
-
-
Login
Diabetes UK received £43.8 million in 2025, but only 6½p in every £1 was committed to new research from its core funds. We look at where the rest goes, who sets the priorities, how much influence ordinary fundraisers really have, and why major funders can negotiate very different terms.
How a billionaire's £50m gift for a type 1 diabetes cure comes with contractual conditions, commercial rights & unanswered questions about research priorities.
Novo Nordisk is adopting the shorter name ‘Novo’ as part of a major global rebrand. Behind the new logo is a wider shift in how one of diabetes’s oldest companies sees healthcare, patients and an increasingly consumer-driven market.
